Nuclera
UKEntry
2024
Hold
2yr
Status
Active
Who owns Nuclera?
Nuclera is a British Biotech company, currently owned by Cambridge Innovation Capital since 2024 and 2 other investors.
Hand-verified · updated 2026-06-30
Open JSON · CC-BY
Most recent investor
Cambridge Innovation CapitalCIC Fund II · 2022 · VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-held by Future Planet Capital, Amadeus Capital Partners and Cambridge Innovation Capital since 2022.
Co-invest · 3 holders · 2022 · present
Future Planet CapitalActive
2022 · present(4yr) · Future Planet Fund I · 2018 · VC
Amadeus Capital PartnersActive
2022 · present(4yr) · Amadeus V Technology Fund · 2021 · VC
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Nuclera?
Nuclera is currently owned by Cambridge Innovation Capital, Future Planet Capital and 1 other, through CIC Fund II, since 2024.
When did Cambridge Innovation Capital and 2 others acquire Nuclera?
Cambridge Innovation Capital and 2 others acquired Nuclera in 2024.
Who has owned Nuclera over time?
Nuclera has been through 3 private-equity ownership periods: Future Planet Capital · via Future Planet Fund I · since 2022; Amadeus Capital Partners · via Amadeus V Technology Fund · since 2022; Cambridge Innovation Capital · via CIC Fund II · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue